All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

Medtech software platform AcuityMD raised $80 million in Series C funding at a $955 million valuation, CEO Michael Monovoukas tells Axios Pro exclusively.

The big picture: Medtech is emerging from a margin squeeze, and AI can help rebuild profitability.

Follow the money: StepStone Group led, joined by Benchmark Capital, Redpoint Ventures, ICONIQ and Atreides Management.

AcuityMD has raised about $160 million total.

How it works: AcuityMD sells intelligence software for sales and marketing teams at medical technology companies.

It's designed to help salespeople identify potential customers and generate leads.

It has also developed AI agents that automate sales call recaps, CRM data entry and pre-call planning.

What's next: The company plans to add new AI use cases, including a tool that can help managers align sales reps to specific territories.

"Our No. 1 goal is to build the best possible experience for the sales rep through AI," Monovoukas says. "So that means providing more and more insights to help them sell, and also automating more and more of their administrative work."

By the numbers: While the majority of Acuity's customers are pre-commercial stage, approximately 40% of its revenue comes from more established players like BD, Zimmer and Olympus Medical Systems.

AcuityMD will have over 500 customers by the end of April, Monovoukas says.

What we're watching: Increased consolidation in medtech could present challenges for medtech services players.

Exclusive: AcuityMD raises $80M for AI-aided medtech sales

Med tech is emerging from a margin squeeze, and AI can help rebuild profitability.

an illustration of a stethoscope forming a dollar sign

Medtech <a class="gtmContentClick" data-vars-link-text="software platform" data-vars-click-url="https://www.axios.com/pro/health-tech-deals/2026/01/20/medtech-ai-health-tech-mergers" data-vars-content-id="da81726f-ee19-4ce9-adef-f4078a08d921" data-vars-headline="Exclusive: AcuityMD raises $80M for AI-aided medtech sales" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/health-tech-deals/2026/01/20/medtech-ai-health-tech-mergers" target="_self">software platform</a> AcuityMD raised $80 million in Series C funding at a $955 million valuation, CEO Michael Monovoukas tells Axios Pro exclusively.The big picture: Medtech is <a class="gtmContentClick" data-vars-link-text="emerging" data-vars-click-url="https://www.supplychaindive.com/news/one-year-in-how-medtech-companies-are-coping-with-tariff-challenges/817194/" data-vars-content-id="da81726f-ee19-4ce9-adef-f4078a08d921" data-vars-headline="Exclusive: AcuityMD raises $80M for AI-aided medtech sales" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.supplychaindive.com/news/one-year-in-how-medtech-companies-are-coping-with-tariff-challenges/817194/" target="_blank">emerging</a> from a <a class="gtmContentClick" data-vars-link-text="margin squeeze" data-vars-click-url="https://www.mckinsey.com/industries/life-sciences/our-insights/what-to-expect-from-medtech-in-2024" data-vars-content-id="da81726f-ee19-4ce9-adef-f4078a08d921" data-vars-headline="Exclusive: AcuityMD raises $80M for AI-aided medtech sales" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.mckinsey.com/industries/life-sciences/our-insights/what-to-expect-from-medtech-in-2024" target="_blank">margin squeeze</a>, and AI can help <a class="gtmContentClick" data-vars-link-text="rebuild" data-vars-click-url="https://www.mckinsey.com/industries/life-sciences/our-insights/scaling-gen-ai-in-the-medtech-industry" data-vars-content-id="da81726f-ee19-4ce9-adef-f4078a08d921" data-vars-headline="Exclusive: AcuityMD raises $80M for AI-aided medtech sales" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.mckinsey.com/industries/life-sciences/our-insights/scaling-gen-ai-in-the-medtech-industry" target="_blank">rebuild</a> profitability.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

transportation

business

c-suite

retail-news

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

salt-lake-city

denver

boulder

kansas-city

austin

chicago

dallas

detroit

washington-dc

atlanta

indianapolis

nashville

nw-arkansas

columbus

richmond

san-francisco

boston

des-moines

houston

phoenix

miami

philadelphia

seattle

new-orleans

colorado-springs

huntsville

raleigh

san-antonio

twin-cities

pittsburgh

arapahoe

douglas

san-diego

tampa-bay

portland

cleveland

axios-local

axios-pro

axios-live

the-axios-show

Exclusive: AcuityMD raises $80M for AI-aided medtech sales

What to read next